Home › Soft Tissue Sarcoma › NCT06482957

Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

Who can join

All ages · All sexes · Healthy volunteers welcome

Patients at any age with a history of sarcoma, with or without evidence of a persistent disease

• For pediatric patients

* Parent/primary caregiver of patient
* Sibling of patient aged 8 years or older

About the study

This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.

What is being tested

• Surveys (other)
• Blood Collection (other)
• Saliva Collection (other)
• Urine Collection (other)
• Stool Collection (other)
• Tissue collection (other)

Sponsor: Vanderbilt-Ingram Cancer Center · Participants: 2,100 · Started: Apr 1, 2022

Contact the study team

• Vanderbilt-Ingram Services for Timely Access · Phone: 800-811-8480

Official record on ClinicalTrials.gov — NCT06482957

Locations in the U.S.

Conditions

• Soft Tissue Sarcoma

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.